The limbic system includes the complex of brain centres, nuclei and connect
ions that provide the anatomical substrate for emotions. Although the prese
nce of small amounts of dopamine (DA) in several limbic structures has been
recognized for a long time, for many years it was thought that limbic DA.
represented a precursor of noradrenaline in the biosynthetic pathway of cat
echolamines. More recent evidence has shown that limbic centres and nuclei
are supplied with a dopaminergic innervation arising from the ventral tegme
ntal area (field A10) and in smaller amounts from the mesencephalic A9 fiel
d. The dopaminergic limbic system is sensitive to ageing. Parameters of dop
aminergic neurotransmission (DA levels, biosynthetic and catabolic markers
and DA receptors) undergo age-related changes which depend on the structure
and species investigated and are characterized mainly by a decline of diff
erent parameters examined. In this paper, the influence of ageing on DA bio
synthesis, levels, metabolism and receptors are reviewed in laboratory rode
nts, monkeys and humans as well as in cases of Alzheimer's disease and Park
inson's disease. The possibility that changes of dopaminergic neurotransmis
sion markers in the limbic system are associated with cognitive impairment
and psychotic symptoms affecting the elderly is discussed. Better knowledge
of dopaminergic neurotransmission mechanisms in the so-called physiologica
l ageing and in senile dementia may provide new insights in the treatment o
f behavioural alterations frequently occurring in old age. (C) 1998 Elsevie
r Science Ireland Ltd. All rights reserved.